BioLife Solutions, Inc. Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest
BioLife Solutions, Inc. (BLFS) reported Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest of $0 for the 12-month period ending 2017-12-31, per its 10-K filed 2018-03-09.
Discontinued › Income Statement › Unrealized Gains
us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest · last filed 2018-03-09
- BioLife Solutions, Inc. comprehensive income (loss), net of tax, attributable to noncontrolling interest for the quarter ending 2017-12-31 was $0.00.
- BioLife Solutions, Inc. comprehensive income (loss), net of tax, attributable to noncontrolling interest for the quarter ending 2017-09-30 was $0.00.
- BioLife Solutions, Inc. comprehensive income (loss), net of tax, attributable to noncontrolling interest for the quarter ending 2017-06-30 was $0.00.
- BioLife Solutions, Inc. comprehensive income (loss), net of tax, attributable to noncontrolling interest for the quarter ending 2017-03-31 was $0.00.
- BioLife Solutions, Inc. comprehensive income (loss), net of tax, attributable to noncontrolling interest for fiscal 2017 was $0.00.
- BioLife Solutions, Inc. comprehensive income (loss), net of tax, attributable to noncontrolling interest for fiscal 2016 was -$1.17M.
- BioLife Solutions, Inc. comprehensive income (loss), net of tax, attributable to noncontrolling interest for fiscal 2015 was -$781.44K.
- BioLife Solutions, Inc. comprehensive income (loss), net of tax, attributable to noncontrolling interest for fiscal 2014 was -$83.05K.
| Period end | Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest 3 month | Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest 6 month | Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest 9 month | Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest 12 month |
|---|---|---|---|---|
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-09 | $0.00 derived: sum of 2 quarters · filed 2018-03-09 | $0.00 derived: sum of 3 quarters · filed 2018-03-09 | $0.00 10-K · filed 2018-03-09 |
| 2017-09-30 | $0.00 10-Q · filed 2017-11-09 | $0.00 derived: sum of 2 quarters · filed 2017-11-09 | $0.00 10-Q · filed 2017-11-09 | -$241.64K derived: sum of 4 quarters · filed 2018-03-09 |
| 2017-06-30 | $0.00 10-Q · filed 2017-08-11 | $0.00 10-Q · filed 2017-08-11 | -$241.64K derived: sum of 3 quarters · filed 2018-03-09 | -$538.61K derived: sum of 4 quarters · filed 2018-03-09 |
| 2017-03-31 | $0.00 10-Q · filed 2017-05-12 | -$241.64K derived: sum of 2 quarters · filed 2018-03-09 | -$538.61K derived: sum of 3 quarters · filed 2018-03-09 | -$902.24K derived: sum of 4 quarters · filed 2018-03-09 |
| 2016-12-31 | -$241.64K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-09 | -$538.61K derived: sum of 2 quarters · filed 2018-03-09 | -$902.24K derived: sum of 3 quarters · filed 2018-03-09 | -$1.17M 10-K · filed 2018-03-09 |
| 2016-09-30 | -$296.97K 10-Q · filed 2017-11-09 | -$660.60K derived: sum of 2 quarters · filed 2017-11-09 | -$924.29K 10-Q · filed 2017-11-09 | -$1.21M derived: sum of 4 quarters · filed 2017-11-09 |
| 2016-06-30 | -$363.63K 10-Q · filed 2017-08-11 | -$627.31K 10-Q · filed 2017-08-11 | -$908.92K derived: sum of 3 quarters · filed 2017-08-11 | -$1.13M derived: sum of 4 quarters · filed 2017-08-11 |
| 2016-03-31 | -$263.69K 10-Q · filed 2017-05-12 | -$545.29K derived: sum of 2 quarters · filed 2017-05-12 | -$768.33K derived: sum of 3 quarters · filed 2017-05-12 | -$924.34K derived: sum of 4 quarters · filed 2017-05-12 |
| 2015-12-31 | -$281.61K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-15 | -$504.64K derived: sum of 2 quarters · filed 2017-03-15 | -$660.66K derived: sum of 3 quarters · filed 2017-03-15 | -$781.44K 10-K · filed 2017-03-15 |
| 2015-09-30 | -$223.03K 10-Q · filed 2016-11-10 | -$379.05K derived: sum of 2 quarters · filed 2016-11-10 | -$499.83K 10-Q · filed 2016-11-10 | -$582.88K derived: sum of 4 quarters · filed 2016-11-10 |
| 2015-06-30 | -$156.02K 10-Q · filed 2016-08-11 | -$276.80K 10-Q · filed 2016-08-11 | -$359.84K derived: sum of 3 quarters · filed 2016-08-11 | -$359.84K derived: sum of 4 quarters · filed 2016-08-11 |
| 2015-03-31 | -$120.78K 10-Q · filed 2016-05-16 | -$203.83K derived: sum of 2 quarters · filed 2016-05-16 | -$203.83K derived: sum of 3 quarters · filed 2016-05-16 | -$203.83K derived: sum of 4 quarters · filed 2016-05-16 |
| 2014-12-31 | -$83.05K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-25 | -$83.05K derived: sum of 2 quarters · filed 2016-02-25 | -$83.05K derived: sum of 3 quarters · filed 2016-02-25 | -$83.05K 10-K · filed 2016-02-25 |
| 2014-09-30 | $0.00 10-Q · filed 2015-11-16 | $0.00 derived: sum of 2 quarters · filed 2015-11-16 | $0.00 10-Q · filed 2015-11-16 | |
| 2014-06-30 | $0.00 10-Q · filed 2015-08-06 | $0.00 10-Q · filed 2015-08-06 | ||
| 2014-03-31 | $0.00 10-Q · filed 2015-05-07 | |||
| 2013-12-31 | $0.00 10-K · filed 2015-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B |